No Data
No Data
Wuhan Easy Diagnosis Biomedicine (002932.SZ): As of July 10th, the total number of shareholders for the company is 31,757.
Wuhan Easy Diagnosis Biomedicine (002932.SZ) stated on the investor interaction platform that as of July 10, 2024, the total number of shareholders in the company was 31,757.
Wuhan Easy Diagnosis Biomedicine (002932.SZ) has accumulated a repurchase of 3.59% of its shares, with a total cost of approximately 163 million yuan.
Wuhan Easy Diagnosis Biomedicine (002932.SZ) announced that as of June 30, 2024, the company repurchased...
Wuhan Easy Diagnosis Biomedicine (002932.SZ): Cumulative expenditure of 160 million yuan to repurchase 3.59% of shares.
Wuhan Easy Diagnosis Biomedicine (002932.SZ) announced that the actual repurchase time range for the share repurchase used to maintain the company's value and shareholder rights and interests is from March 27, 2024 to June 17, 2024. The company repurchased a total of 8,349,718 shares of the company through a share repurchase dedicated securities account, accounting for 3.59% of the total share capital of the company, with a highest fill price of 20.98 yuan/share, a lowest fill price of 18.17 yuan/share, and a total payment of 162,914,607.58 yuan (excluding transaction fees) using centralized bidding trading.
Wuhan Easy Diagnosis Biomedicine (002932.SZ): has cumulatively repurchased 3.10% of shares.
On June 6, Gelunhui reported that Wuhan Easy Diagnosis Biomedicine (002932.SZ) announced that as of June 6, 2024, the company had cumulatively repurchased 7,201,536 shares of the company's stock through a special repurchase securities account in a centralized bidding manner, accounting for 3.10% of the total share capital of the company; the highest transaction price for the repurchased shares was 20.98 yuan/share, the lowest transaction price was 18.17 yuan/share, and the total transaction amount was 142 million yuan (excluding transaction fees).
Wuhan Easy Diagnosis Biomedicine (002932.SZ) has cumulatively repurchased 2.31% of its shares.
On June 3, Gelonhui reported that Wuhan Easy Diagnosis Biomedicine (002932.SZ) announced that as of May 31, 2024, the company repurchased 5,367,031 shares through a repurchase special securities account in a centralized bidding manner, accounting for 2.31% of the company's total equity; The highest fill price for repurchased shares was 20.98 yuan/share, the lowest fill price was 18.60 yuan/share, and the total transaction amount was RMB 107,570,789.13 (excluding transaction taxes and fees).
Matilda Biotech (002932.SZ) 2023 equity distribution: 1.20 yuan for every 10 shares
Mingde Biotech (002932.SZ) announced that the company's 2023 profit distribution plan is to distribute RMB 1.20 in cash (tax included) to all shareholders for every 10 shares based on the current total share capital after excluding the repurchased shares. The share registration date for this equity distribution is: May 27, 2024, and the exclusion date is May 28, 2024.
No Data